Resmed (RSMDF) Enterprise Value (2009 - 2026)

Resmed has reported Enterprise Value for 18 years, with the latest figure at -$1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 78.03% year-over-year to -$1.7 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.7 billion (down 78.03% YoY), and the FY2025 full-year result was -$1.2 billion, down 407.4% from the prior year.
• Enterprise Value for Q1 2026 stood at -$1.7 billion, down from -$1.4 billion in the prior quarter.
• The five-year high for Enterprise Value was -$201.8 million in Q1 2022, with the low at -$1.7 billion in Q1 2026.
• Historically, Enterprise Value has averaged -$578.8 million across 5 years, with a median of -$253.2 million in 2022.
• Annual changes were most pronounced in 2022 — Enterprise Value climbed 24.98% — and 2025, when it plunged 407.4%.
• Resmed's Enterprise Value stood at -$253.2 million in 2022, then grew by 16.96% to -$210.2 million in 2023, then plunged by 148.25% to -$521.9 million in 2024, then sank by 171.5% to -$1.4 billion in 2025, then declined by 17.18% to -$1.7 billion in 2026.
• The last three Enterprise Value figures came in at -$1.7 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.4 billion (Q3 2025), per Business Quant data.